You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Baraclude
Baraclude is the brand name for entecavir, an antiviral medication used to treat chronic hepatitis B virus (HBV) infection. It is classified as a nucleoside analog and works by inhibiting the replication of the hepatitis B virus in the liver, thereby reducing the amount of virus in the body. This helps to lower the risk of developing complications from chronic hepatitis B, such as liver damage, cirrhosis, and liver cancer.
Drug Availability and Controlled Substance Status
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Baraclude ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How long do I need to take Baraclude?
Treatment duration with Baraclude can vary depending on the patient's response and medical condition. It may be necessary to continue treatment for several years, or even indefinitely, to maintain viral suppression and prevent disease progression.
Can Baraclude cure hepatitis B?
Baraclude is not a cure for hepatitis B, but it helps control the virus and reduces the risk of liver damage. Continuous treatment is often necessary to keep the virus suppressed.
What should I do if I miss a dose of Baraclude?
If you miss a dose of Baraclude, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose.
Is it safe to stop taking Baraclude once I feel better?
No, you should not stop taking Baraclude without consulting your healthcare provider. Discontinuing treatment can lead to a flare-up of hepatitis B, which can cause severe liver damage. Your healthcare provider will monitor your condition and advise you on when and how to stop treatment if necessary.
Can I take Baraclude with other medications?
Baraclude may interact with other medications, so it is important to inform your healthcare provider of all medications and supplements you are taking. This includes over-the-counter drugs and herbal products. Your provider will determine if any adjustments to your treatment plan are needed.
Is alcohol consumption safe while on Baraclude treatment?
- It's usually recommended to limit alcohol intake during the treatment since it might increase the risk of liver damage.
Comprehensive Drug Guide
How Does Baraclude Work?
Entecavir, the active ingredient in Baraclude, works by inhibiting the hepatitis B virus (HBV) DNA polymerase, an enzyme critical for the replication of the virus. By preventing the virus from multiplying, Baraclude helps to reduce the amount of HBV in the body, slow the progression of liver disease, and improve liver function over time.
What is Baraclude Used For?
Treatment of Chronic Hepatitis B Virus (HBV) Infection: In adults and children 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Common Dosages
Baraclude is available by prescription only and is not classified as a controlled substance. It is supplied as oral tablets and oral solution for use in both adults and children.
Administration: Baraclude should be taken on an empty stomach (at least 2 hours before or 2 hours after a meal) to maximize absorption. The tablets should be swallowed whole with water. The oral solution is available for those who have difficulty swallowing tablets.
Duration of Use: The duration of treatment with Baraclude depends on the patient's response and medical condition. Continuous treatment is often required to maintain suppression of HBV and prevent disease progression.
Typical Dosing
FDA Approved Indications
The typical dosage of Baraclude varies based on the patient’s treatment history and liver function:
- For Adults with Compensated Liver Disease:
- Treatment-Naïve Patients: 0.5 mg once daily.
- Lamivudine-Refractory Patients: 1 mg once daily.
- For Adults with Decompensated Liver Disease: 1 mg once daily.
- For Pediatric Patients (2 years and older): The dose is based on body weight and is typically 0.015 mg/kg up to a maximum of 0.5 mg once daily.
Who Shouldn't Take Baraclude?
Baraclude is contraindicated in patients with:
- Known hypersensitivity to entecavir or any component of the product.
Advice From The Pharmacist
Patients using Baraclude should be advised to:
- Take the medication exactly as prescribed and not to skip doses, as this can lead to the development of drug-resistant strains of HBV.
- Continue regular follow-up appointments with their healthcare provider to monitor liver function and viral load.
- Inform their healthcare provider of any changes in their health, especially new or worsening symptoms of liver disease.
- Avoid consuming alcohol, as it can increase the risk of liver damage.
- Be aware of potential drug interactions, especially if they are taking other medications for HBV or HIV.
Side Effects of Baraclude
Common Side Effects
Common side effects of Baraclude may include:
- Headache
- Fatigue
- Dizziness
- Nausea
- Diarrhea
- Upper respiratory tract infection
Uncommon/Severe Side Effects
Serious side effects can include:
- Lactic Acidosis: A rare but serious condition characterized by symptoms such as muscle pain, weakness, trouble breathing, stomach pain, nausea, vomiting, and feeling cold. Immediate medical attention is required if these symptoms occur.
- Severe Hepatomegaly with Steatosis: Enlargement of the liver with fat accumulation, which can be life-threatening.
Exacerbation of Hepatitis: Upon discontinuation of Baraclude, patients may experience a flare-up of hepatitis symptoms. Regular monitoring is required if treatment is stopped.
Risks and Warnings of Baraclude
- Lactic Acidosis and Hepatomegaly: Nucleoside analogs, including entecavir, have been associated with lactic acidosis and severe hepatomegaly with steatosis, including fatal cases. These conditions are more likely to occur in patients with advanced liver disease.
- Exacerbation of Hepatitis after Discontinuation: Patients who discontinue Baraclude may experience a severe exacerbation of hepatitis. Liver function should be monitored closely after stopping treatment.
HIV Coinfection: Baraclude is not recommended for patients with both HIV and HBV who are not receiving highly active antiretroviral therapy (HAART) due to the risk of developing resistance to HIV medications.
Interactions with Baraclude
Common Drug Interactions
Baraclude may interact with other medications, including:
- HIV Medications: Concurrent use of Baraclude with certain antiretroviral drugs may increase the risk of resistance. Patients should inform their healthcare provider if they are being treated for HIV.
- Other Antivirals: Combining Baraclude with other nucleoside analogs may increase the risk of lactic acidosis and liver damage.
- Immunosuppressants: Patients should inform their healthcare provider if they are taking immunosuppressants, as these can affect the response to Baraclude.
Alternatives to Baraclude
Alternative treatments for chronic hepatitis B include:
- Other Antiviral Medications: Such as tenofovir (Viread), lamivudine (Epivir), or adefovir (Hepsera).
- Interferon Therapy: Such as peginterferon alfa-2a (Pegasys), which can be used in certain cases of chronic hepatitis B.
- Combination Therapy: In some cases, a combination of antivirals may be used to reduce the risk of resistance.
The choice of treatment depends on the patient's specific condition, treatment history, and the presence of any comorbid conditions.
